Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
12048 | 871 | 33.9 | 81% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
79 | 26608 | DIABETES CARE//DIABETES EDUCATOR//DIABETES TECHNOLOGY & THERAPEUTICS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INTERMITTENT GLUCOSE | Author keyword | 15 | 88% | 1% | 7 |
2 | POSTPRANDIAL HYPERGLYCEMIA | Author keyword | 12 | 23% | 5% | 44 |
3 | GLYCEMIC VARIABILITY | Author keyword | 11 | 39% | 3% | 22 |
4 | GLYCAEMIC VARIABILITY | Author keyword | 9 | 48% | 2% | 14 |
5 | EXCELLENCE DIABET ENDOCRINOL | Address | 9 | 83% | 1% | 5 |
6 | GLUCOSE VARIABILITY | Author keyword | 7 | 29% | 2% | 21 |
7 | CONTINUOUS GLUCOSE MONITORING | Author keyword | 6 | 14% | 5% | 44 |
8 | CARDIO P METAB | Address | 6 | 30% | 2% | 16 |
9 | GLUCOSE SPIKE | Author keyword | 6 | 100% | 0% | 4 |
10 | HBA1C VARIABILITY | Author keyword | 6 | 100% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INTERMITTENT GLUCOSE | 15 | 88% | 1% | 7 | Search INTERMITTENT+GLUCOSE | Search INTERMITTENT+GLUCOSE |
2 | POSTPRANDIAL HYPERGLYCEMIA | 12 | 23% | 5% | 44 | Search POSTPRANDIAL+HYPERGLYCEMIA | Search POSTPRANDIAL+HYPERGLYCEMIA |
3 | GLYCEMIC VARIABILITY | 11 | 39% | 3% | 22 | Search GLYCEMIC+VARIABILITY | Search GLYCEMIC+VARIABILITY |
4 | GLYCAEMIC VARIABILITY | 9 | 48% | 2% | 14 | Search GLYCAEMIC+VARIABILITY | Search GLYCAEMIC+VARIABILITY |
5 | GLUCOSE VARIABILITY | 7 | 29% | 2% | 21 | Search GLUCOSE+VARIABILITY | Search GLUCOSE+VARIABILITY |
6 | CONTINUOUS GLUCOSE MONITORING | 6 | 14% | 5% | 44 | Search CONTINUOUS+GLUCOSE+MONITORING | Search CONTINUOUS+GLUCOSE+MONITORING |
7 | GLUCOSE SPIKE | 6 | 100% | 0% | 4 | Search GLUCOSE+SPIKE | Search GLUCOSE+SPIKE |
8 | HBA1C VARIABILITY | 6 | 100% | 0% | 4 | Search HBA1C+VARIABILITY | Search HBA1C+VARIABILITY |
9 | NEMOES | 6 | 100% | 0% | 4 | Search NEMOES | Search NEMOES |
10 | GLUCOSE FLUCTUATION | 5 | 54% | 1% | 7 | Search GLUCOSE+FLUCTUATION | Search GLUCOSE+FLUCTUATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GLYCEMIC VARIABILITY | 20 | 39% | 5% | 41 |
2 | OXIDATIVE STRESS GENERATION | 9 | 44% | 2% | 16 |
3 | LONG TERM INSTABILITY | 8 | 70% | 1% | 7 |
4 | ASYMPTOMATIC HYPERGLYCEMIA | 8 | 35% | 2% | 19 |
5 | INTERMITTENT HIGH GLUCOSE | 8 | 56% | 1% | 10 |
6 | ENHANCES APOPTOSIS | 7 | 32% | 2% | 18 |
7 | POSTCHALLENGE PLASMA GLUCOSE | 7 | 41% | 1% | 13 |
8 | POSTPRANDIAL HYPERGLYCEMIA | 7 | 11% | 7% | 60 |
9 | IMPORTANT TREATMENT TARGET | 6 | 80% | 0% | 4 |
10 | HEART2D TRIAL | 6 | 71% | 1% | 5 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Glucose Variability; Does It Matter? | 2010 | 111 | 60 | 35% |
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting | 2010 | 56 | 53 | 55% |
Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes | 2014 | 4 | 47 | 70% |
Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives | 2012 | 12 | 44 | 86% |
Effects of sitagliptin or mitiglinide as an add-on to acarbose on daily blood glucose fluctuations measured by 72 h subcutaneous continuous glucose monitoring in Japanese patients with type 2 diabetes: a prospective randomized study | 2014 | 4 | 29 | 66% |
Postprandial Hyperglycemia/Hyperlipidemia (Postprandial dysmetabolism) is a cardiovascular risk factor | 2007 | 146 | 47 | 36% |
The glycemic/metabolic responses to meal tolerance tests at breakfast, lunch and dinner, and effects of the mitiglinide/voglibose fixed-dose combination on postprandial profiles in Japanese patients with type 2 diabetes mellitus | 2014 | 2 | 20 | 70% |
The glycemic triumvirate and diabetic complications: Is the whole greater than the sum of its component parts? | 2012 | 15 | 36 | 44% |
Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings | 2008 | 34 | 62 | 66% |
Do data in the literature indicate that glycaemic variability is a clinical problem? Glycaemic variability and vascular complications of diabetes | 2013 | 4 | 40 | 65% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EXCELLENCE DIABET ENDOCRINOL | 9 | 83% | 0.6% | 5 |
2 | CARDIO P METAB | 6 | 30% | 1.8% | 16 |
3 | PATHOL MED EXPT CLIN | 5 | 40% | 1.1% | 10 |
4 | HUMAN NUTR ATHEROSCLEROSIS | 4 | 75% | 0.3% | 3 |
5 | HUMAN NUTR ATHEROGENESIS | 3 | 57% | 0.5% | 4 |
6 | INTERNAL MED METAB DIS UNIT | 1 | 38% | 0.3% | 3 |
7 | INNOVAT DIABET TREATMENT | 1 | 33% | 0.3% | 3 |
8 | OUTPATIENT CLIN METAB | 1 | 30% | 0.3% | 3 |
9 | ADJ | 1 | 50% | 0.1% | 1 |
10 | CLIN CG CARUS | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000275293 | NATEGLINIDE//KAD 1229//REPAGLINIDE |
2 | 0.0000208406 | INSULIN GLARGINE//INSULIN DETEMIR//BIPHASIC INSULIN ASPART 30 |
3 | 0.0000195273 | ACARBOSE//ALPHA GLUCOSIDASE INHIBITOR//MIGLITOL |
4 | 0.0000147612 | SILENT MYOCARDIAL ISCHAEMIA//SILENT CORONARY ARTERY DISEASE//SILENT MYOCARDIAL ISCHEMIA |
5 | 0.0000141966 | IMPAIRED FASTING GLUCOSE//DIABETES PREVENTION//IMPAIRED GLUCOSE TOLERANCE |
6 | 0.0000134800 | ARTIFICIAL PANCREAS//DIABETES TECHNOLOGY & THERAPEUTICS//INSULIN DOSAGE ADJUSTMENT |
7 | 0.0000102550 | METABOLIC MEMORY//HYPERGLYCEMIC MEMORY//EPIGEN PROFILING IL |
8 | 0.0000092515 | HBA1C//GLYCATED ALBUMIN//GLYCATED HEMOGLOBIN |
9 | 0.0000082380 | PROINSULIN//INTACT PROINSULIN//SPLIT PROINSULIN |
10 | 0.0000078743 | MULTIPLE CAUSE//CHRONIC COMPLICATIONS//DATASUS |